Nordic Nanovector appoints experienced biotech executive Pierre Dodion MD as Chief Medical Officer
Oslo, Norway, 8 November 2021 Nordic Nanovector ASA (OSE: NANO) announces the appointment of Pierre Dodion MD as Chief Medical Officer (CMO). Dr Dodion is taking over the role from Dr Christine Wilkinson Blanc, who is leaving the Company for personal reasons. Dr Wilkinson Blanc will remain with the Company until January 2022 to ensure a smooth transition. Dr Dodion joins Nordic Nanovector from Immunooncology Partners, a consultancy he founded to support biotech companies in clinical development, medical affairs and business development activities. In this role, he has acted as a